Therapy News and Research

RSS

Sexual side effects of cancer treatment discussed less frequently with female patients

A new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.

24 Oct 2022

Celebrating the Alderley Park Grand Opening

HQ Plasmid Center of Excellence based at UK life science hotspot now open for business.

From Charles Rivers Laboratories Cell and Gene Therapy 24 Oct 2022

Combining host gene expression profiling and metagenomic pathogen detection from plasma nucleic acid enables accurate sepsis diagnosis

Researchers developed integrated host-microbe plasma metagenomics to facilitate sepsis diagnosis.

24 Oct 2022

Effectiveness of COVID-19 vaccines in preventing hospitalizations among immunocompromised adults

Researchers investigated the efficacy of monovalent mRNA COVID-19 vaccines in immunocompromised adults during the Omicron dominance period starting December 2021.

24 Oct 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

Scientists discover molecular link between lung tumor growth and disrupted circadian rhythms

Scientists discovered an important molecular link between lung tumor growth and disrupted circadian rhythms, according to a new paper co-authored by a University of Rochester Wilmot Cancer Institute investigator and led by the Scripps Research Institute in California.

21 Oct 2022

New research could have major implications for minimally invasive, robotically delivered brain surgery

The early-stage research tested the delivery and safety of the new implantable catheter design in two sheep to determine its potential for use in diagnosing and treating diseases in the brain.

21 Oct 2022

The acceptability of a language support system by nurses

At the end of a working day, nurses have covered quite a few kilometers. They would like to save themselves some of the trips. Voice assistants might help do just that.

21 Oct 2022

Exploring SARS-CoV-2-associated endothelial dysfunction

A new study described the evidence, mechanisms, and therapies for endothelial dysfunction in coronavirus disease 2019 (COVID-19).

21 Oct 2022

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models.

21 Oct 2022

Vast majority of people with gender dysphoria continue using gender-affirming hormone treatment

Among individuals treated at a gender identity clinic in The Netherlands, those who used puberty supressing treatment before the age of 18 and then started gender-affirming hormones, 98% (704 out of 720) continued use at follow-up, according to an observational study published in The Lancet Child & Adolescent Health journal.

20 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Male mice three times more likely than females to survive E. coli infection

Scientists at UC San Francisco have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Frontotemporal dementia (FTD) is one of the most common causes of progressive dementia in working-age people.

20 Oct 2022

Study identifies gene mutations that impact radiation resistance and sensitivity

A new Northwestern Medicine study identifies common and rare gene mutations that impact radiation resistance and sensitivity, an important step toward providing more individualized and effective radiotherapy for patients with cancer.

20 Oct 2022

Researchers circumvent a key mechanism in castration-resistant prostate cancer

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that they can circumvent a key mechanism in castration-resistant prostate cancer (CRPC) and possibly make immunotherapies more effective.

20 Oct 2022

Therapy News and Research

Sexual side effects of cancer treatment discussed less frequently with female patients

Celebrating the Alderley Park Grand Opening

Combining host gene expression profiling and metagenomic pathogen detection from plasma nucleic acid enables accurate sepsis diagnosis

Effectiveness of COVID-19 vaccines in preventing hospitalizations among immunocompromised adults

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Scientists discover molecular link between lung tumor growth and disrupted circadian rhythms

New research could have major implications for minimally invasive, robotically delivered brain surgery

The acceptability of a language support system by nurses

Exploring SARS-CoV-2-associated endothelial dysfunction

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Vast majority of people with gender dysphoria continue using gender-affirming hormone treatment

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Male mice three times more likely than females to survive E. coli infection

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

TDP-43 can be useful biomarker for identifying neuropathological subtypes of frontotemporal dementia

Study identifies gene mutations that impact radiation resistance and sensitivity

Researchers circumvent a key mechanism in castration-resistant prostate cancer

What are the complications, preventative measures, and treatments of ocular monkeypox?

Shopping vouchers aid in cessation of smoking among pregnant women

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News